Search Results

You are looking at 1 - 10 of 23 items for :

  • "Intrahepatic cholangiocarcinoma" x
  • Refine by Access: All x
Clear All
Full access

Kwang-Yu Chang, Jang-Yang Chang, and Yun Yen

: medical conditions and lifestyle: results from a European multicentre case-control study . Eur J Gastroenterol Hepatol 2007 ; 19 : 623 – 630 . 11 Shaib YH El-Serag HB Davila JA . Risk factors of intrahepatic cholangiocarcinoma in the United

Full access

Shreekant Parasuraman, Lincy Lal, Scott Bunner, Dilan Paranagama, Anna Teschemaker, Susan Snodgrass, and Smitha Sivaraman

Full access

Shiva Kumar R. Mukkamalla, Hussain M. Naseri, Byung M. Kim, Steven C. Katz, and Vincent A. Armenio

. Temporal trends in age-adjusted incidence rates of cholangiocarcinoma by anatomic location. Abbreviations: ECC, extrahepatic cholangiocarcinoma; ICC, intrahepatic cholangiocarcinoma. Figure 3. Temporal trends in age-adjusted incidence rates

Full access

Al B. Benson III, Michael I. D’Angelica, Thomas A. Abrams, Chandrakanth Are, P. Mark Bloomston, Daniel T. Chang, Bryan M. Clary, Anne M. Covey, William D. Ensminger, Renuka Iyer, R. Kate Kelley, David Linehan, Mokenge P. Malafa, Steven G. Meranze, James O. Park, Timothy Pawlik, James A. Posey, Courtney Scaife, Tracey Schefter, Elin R. Sigurdson, G. Gary Tian, Jean-Nicolas Vauthey, Alan P. Venook, Yun Yen, Andrew X. Zhu, Karin G. Hoffmann, Nicole R. McMillian, and Hema Sundar

cholangiocarcinomas are more common than intrahepatic cholangiocarcinomas. Intrahepatic cholangiocarcinomas (also known as peripheral cholangiocarcinomas ) are located within the hepatic parenchyma and have also been called peripheral cholangiocarcinomas (see

Full access

Anil K. Rengan and Crystal S. Denlinger

Intrahepatic cholangiocarcinoma (iCCA) historically presents with advanced stage and poor prognosis. Although conventional chemotherapy is the mainstay of treatment, targeted therapy has proven effective for patients with specific molecular

Full access

Olumide Gbolahan, Neda Hashemi-Sadraei, and Bert O’Neil

Intrahepatic cholangiocarcinoma (iCCA) remains recalcitrant to treatment, with a median survival of only 26 to 30 months in localized and resectable disease. 1 , 2 In the more common locally advanced/metastatic setting, outcomes are even more dire

Full access

Michael A. Cilento, Nicola K. Poplawski, Sellvakumaram Paramasivam, David M. Thomas, and Ganessan Kichenadasse

Research; AO, anaplastic oligodendroglioma; CUP, cancer of unknown primary; ESC, endometrial serious adenocarcinoma; HGSOC, high-grade serous ovarian carcinoma; IBC, invasive breast carcinoma; ICC, intrahepatic cholangiocarcinoma; IDC, invasive ductal

Full access

Al B. Benson III, Thomas A. Abrams, Edgar Ben-Josef, P. Mark Bloomston, Jean F. Botha, Bryan M. Clary, Anne Covey, Steven A. Curley, Michael I. D'Angelica, Rene Davila, William D. Ensminger, John F. Gibbs, Daniel Laheru, Mokenge P. Malafa, Jorge Marrero, Steven G. Meranze, Sean J. Mulvihill, James O. Park, James A. Posey, Jasgit Sachdev, Riad Salem, Elin R. Sigurdson, Constantinos Sofocleous, Jean-Nicolas Vauthey, Alan P. Venook, Laura Williams Goff, Yun Yen, and Andrew X. Zhu

. Gallbladder and biliary tract carcinoma: a comprehensive update, part 1 . Oncology (Williston Park) 2004 ; 18 : 889 – 896 . 164 Yamamoto S Kubo S Hai S . Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma

Full access

Muhammed Aasim Yusuf, Vinay Kumar Kapoor, Refaat Refaat Kamel, Ather Kazmi, Najam Uddin, Nehal Masood, and Abdulmajeed Al-Abdulkareem

: hepatocellular cancer, cancer of the gallbladder, extrahepatic cholangiocarcinoma, and intrahepatic cholangiocarcinoma. The incidence of hepatocellular cancer seems to be significantly higher in the Middle East and North Africa (MENA) region than in the West

Full access

Amy Zhou, Manik Amin, Kathryn J. Fowler, Elizabeth M. Brunt, Jesse Keller, and Benjamin Tan

(H-B)PLCs have been increasingly recognized as distinct from hepatocellular carcinomas (HCCs) and intrahepatic cholangiocarcinomas (ICCs) since the first report in 1903 by Wells 2 and further characterization by Allen and Lisa 3 in 1949. In general, patients